These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5681046)

  • 21. Theory of antimotion sickness drug mechanisms.
    Wood CD; Graybiel A
    Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacologic agents for preventing and treating motion sickness].
    Shashkov VS; Sabaev VV
    Kosm Biol Aviakosm Med; 1981; 15(1):9-18. PubMed ID: 6111621
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical aviation and aerospace medicine. Bethanechol chloride in the treatment of motion sickness: negative results.
    Godbey AL
    Aerosp Med; 1969 Apr; 40(4):432-3. PubMed ID: 4887846
    [No Abstract]   [Full Text] [Related]  

  • 24. Transdermally administered scopolamine.
    Paasuke RT
    CMAJ; 1985 Nov; 133(10):956. PubMed ID: 4063911
    [No Abstract]   [Full Text] [Related]  

  • 25. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental assessment of selected antimotion drugs.
    Matsnev EI; Bodo D
    Aviat Space Environ Med; 1984 Apr; 55(4):281-6. PubMed ID: 6732678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the treatment of motion sickness].
    GRUHLER J
    Dtsch Med Wochenschr; 1955 Jan; 80(3):108-10. PubMed ID: 14352764
    [No Abstract]   [Full Text] [Related]  

  • 29. [The neurochemical mechanisms and pharmacological routes to eliminate vomiting in seasickness].
    Naletov SV; Beletskiĭ EA
    Voen Med Zh; 1998 Sep; 319(9):74-6. PubMed ID: 9817022
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and treatment of air sickness.
    BERGIN KG
    Practitioner; 1957 May; 178(1067):626-8. PubMed ID: 13431615
    [No Abstract]   [Full Text] [Related]  

  • 31. The medical hazards of sailing.
    Kemp R
    Practitioner; 1975 Aug; 215(1286):188-96. PubMed ID: 1178620
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis.
    Gupta VK
    Med Hypotheses; 2005; 64(6):1177-81. PubMed ID: 15823712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of No-Shpa in combination with vitamins in motion sickness].
    Usachev VV; Sabaev VV; Matveev AD; Popov AG
    Kosm Biol Aviakosm Med; 1981; 15(3):82-3. PubMed ID: 7289553
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1982 Aug; 53(8):770-2. PubMed ID: 7181807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasickness tables.
    COLES RR; HEAD PW
    J R Nav Med Serv; 1958; 44(3):205-13. PubMed ID: 13588669
    [No Abstract]   [Full Text] [Related]  

  • 38. Mal de debarquement presenting in the Emergency Department.
    DeFlorio PT; Silbergleit R
    J Emerg Med; 2006 Nov; 31(4):377-9. PubMed ID: 17046477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of motion sickness by intranasal medication.
    CHINN HI; HYDE RW; MILCH LJ
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):666-9. PubMed ID: 13289870
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945.
    Wood CD; Graybiel A; Kennedy RS
    Res Rep U S Nav Sch Aviat Med; 1965 Jul; ():1-9. PubMed ID: 5322559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.